Recent Quotes (30 days)

You have no recent quotes
chg | %

Vetoquinol SA news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

VETO 56.00 -0.20 (-0.36%)
price chart
Vetoquinol: 2015 Results
The Vetoquinol Group posted 2015 sales of €342.6 million, up 8.7% on reported data and up 3.7% at constant exchange rates.
Vetoquinol Acquires Equity Stake in Plant Advanced Technologies PAT
Vetoquinol (Paris:VETO), a leading player in the animal health sector, and Plant Advanced Technologies PAT, a plant biotechnology company, announce Vetoquinol's acquisition of an equity stake in Plant Advanced Technologies PAT. The transaction was ...
Global Pet Oral Care Market 2017 – Nestle, Petzlife Product Inc., Vetoquinol ...
Latest Pet Oral Care market research report 2017 determines an array of factors including manufacture analysis, share, size, sales, forecast trends, production, supply, industry, demands, and CAGR.
Vetoquinol Names Dr. Eric M. Alsup as Country Manager, USA
Headquartered in Fort Worth, Texas, Vetoquinol USA—makers of Vetoquinol-branded products and the former Vet Solutions� product portfolio—is owned by Vetoquinol SA, a family-owned, independent French pharmaceutical company founded in 1933. Dedicated ...
Related articles »  
Vetoquinol: 2018 Calendar of Financial Communication
Vetoquinol is a leading global animal health company that supplies drugs and non-medicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets.
Vetoquinol SA (VETO) Moves Up 0.56% on Nov 24
Shares of Vetoquinol SA (EPA:VETO) last traded at 55.54, representing a move of 0.56%, or 0.31 per share, on volume of 227 shares.
, an Innovative Drug for Congestive Heart Failure in Dogs
Cardiac diseases are common amongst dogs, currently affecting around 10% of canines, an increasing percentage in conjunction with the aging of the population.
Global Animal Pharmaceuticals Market to Grow at a CAGR of 7.7%, 2016-2022 With ...
The global animal pharmaceuticals market was valued at $12,614.3 million in 2015, and it is expected to grow at a CAGR of 7.7% during 2016 - 2022.
Vetoquinol USA Sponsoring Retired Racehorse Project
Vetoquinol USA, the veterinary pharmaceutical company dedicated to developing animal health products with veterinarian-approved formulas for the last 80 years, recently announced its sponsorship with the Retired Racehorse Project.
Global Veterinary Therapeutics Market 2017 Top Players : Virbac, Bayer AG ...
The market study on world Veterinary Therapeutics Market 2017 analysis Report studies current still as future aspects of the Veterinary Therapeutics Market based upon factors on that the businesses vie within the market, key trends and segmentation ...